BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12900899)

  • 21. Clinicopathologic and Molecular Characteristics of Familial Cherubism with Associated Odontogenic Tumorous Proliferations.
    Argyris PP; Gopalakrishnan R; Hu Y; Reichenberger EJ; Koutlas IG
    Head Neck Pathol; 2018 Mar; 12(1):136-144. PubMed ID: 28721660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Molecular and Cellular Pathogenesis of Cherubism].
    Ueki Y
    Clin Calcium; 2016 Jun; 26(6):918-26. PubMed ID: 27230848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Jawing about TNF: new hope for cherubism.
    Novack DV; Faccio R
    Cell; 2007 Jan; 128(1):15-7. PubMed ID: 17218248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cherubism allele heterozygosity amplifies microbe-induced inflammatory responses in murine macrophages.
    Prod'Homme V; Boyer L; Dubois N; Mallavialle A; Munro P; Mouska X; Coste I; Rottapel R; Tartare-Deckert S; Deckert M
    J Clin Invest; 2015 Apr; 125(4):1396-400. PubMed ID: 25705883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pro416Arg cherubism mutation in Sh3bp2 knock-in mice affects osteoblasts and alters bone mineral and matrix properties.
    Wang CJ; Chen IP; Koczon-Jaremko B; Boskey AL; Ueki Y; Kuhn L; Reichenberger EJ
    Bone; 2010 May; 46(5):1306-15. PubMed ID: 20117257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [SH3BP2 heterozygous mutation amplifies macrophage inflammatory responses to infection in a mouse model of cherubism].
    Deckert M; Prod'Homme V
    Med Sci (Paris); 2015; 31(6-7):589-91. PubMed ID: 26152156
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of SH3BP2 in the pathophysiology of cherubism.
    Reichenberger EJ; Levine MA; Olsen BR; Papadaki ME; Lietman SA
    Orphanet J Rare Dis; 2012 May; 7 Suppl 1(Suppl 1):S5. PubMed ID: 22640988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA analysis of the SH3BP2 gene in patients with aggressive central giant cell granuloma.
    de Lange J; van Maarle MC; van den Akker HP; Redeker EJ
    Br J Oral Maxillofac Surg; 2007 Sep; 45(6):499-500. PubMed ID: 16713042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cherubism].
    Brix M; Peters H; Lebeau J
    Rev Stomatol Chir Maxillofac; 2009 Nov; 110(5):293-8. PubMed ID: 19836038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SH3BP2-encoding exons involved in cherubism are not associated with central giant cell granuloma.
    Teixeira RC; Horz HP; Damante JH; Garlet GP; Santos CF; Nogueira RL; Cavalcante RB; Conrads G
    Int J Oral Maxillofac Surg; 2011 Aug; 40(8):851-5. PubMed ID: 21680150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cherubism gene Sh3bp2 is important for optimal bone formation, osteoblast differentiation, and function.
    Mukherjee PM; Wang CJ; Chen IP; Jafarov T; Olsen BR; Ueki Y; Reichenberger EJ
    Am J Orthod Dentofacial Orthop; 2010 Aug; 138(2):140.e1-140.e11; discussion 140-1. PubMed ID: 20691350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cherubism as a systemic skeletal disease: evidence from an aggressive case.
    Morice A; Joly A; Ricquebourg M; Maruani G; Durand E; Galmiche L; Amiel J; Vial Y; Cavé H; Belhous K; Piketty M; Cohen-Solal M; Berdal A; Collet C; Picard A; Coudert AE; Kadlub N
    BMC Musculoskelet Disord; 2020 Aug; 21(1):564. PubMed ID: 32825821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Genetic aspects of cherubism].
    Brix M; Peters H; Ranfaing E; Ricbourg B
    Rev Stomatol Chir Maxillofac; 2006 Apr; 107(2):105-8. PubMed ID: 16738517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cherubism. A case report.
    Cariati P; Monsalve Iglesias F; Fernández Solís J; Valencia Laseca A; Martinez Lara I
    Reumatol Clin; 2017; 13(6):352-353. PubMed ID: 27427211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Etanercept administration to neonatal SH3BP2 knock-in cherubism mice prevents TNF-α-induced inflammation and bone loss.
    Yoshitaka T; Ishida S; Mukai T; Kittaka M; Reichenberger EJ; Ueki Y
    J Bone Miner Res; 2014; 29(5):1170-82. PubMed ID: 24978678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone marrow transplantation improves autoinflammation and inflammatory bone loss in SH3BP2 knock-in cherubism mice.
    Yoshitaka T; Kittaka M; Ishida S; Mizuno N; Mukai T; Ueki Y
    Bone; 2015 Feb; 71():201-9. PubMed ID: 25445458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cherubism: best clinical practice.
    Papadaki ME; Lietman SA; Levine MA; Olsen BR; Kaban LB; Reichenberger EJ
    Orphanet J Rare Dis; 2012 May; 7 Suppl 1(Suppl 1):S6. PubMed ID: 22640403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cherubism: a systematic literature review of clinical and molecular aspects.
    Chrcanovic BR; Guimarães LM; Gomes CC; Gomez RS
    Int J Oral Maxillofac Surg; 2021 Jan; 50(1):43-53. PubMed ID: 32620450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cherubism Mice Also Deficient in c-Fos Exhibit Inflammatory Bone Destruction Executed by Macrophages That Express MMP14 Despite the Absence of TRAP+ Osteoclasts.
    Kittaka M; Mayahara K; Mukai T; Yoshimoto T; Yoshitaka T; Gorski JP; Ueki Y
    J Bone Miner Res; 2018 Jan; 33(1):167-181. PubMed ID: 28914985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cherubism - new hypotheses on pathogenesis and therapeutic consequences.
    Hyckel P; Berndt A; Schleier P; Clement JH; Beensen V; Peters H; Kosmehl H
    J Craniomaxillofac Surg; 2005 Feb; 33(1):61-8. PubMed ID: 15694152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.